Sarah Taylor, VP of Science at Lightcast, discusses how functional single-cell analysis can complement existing technologies, improve early-stage drug discovery decisions and help researchers identify promising candidates by measuring what cells do. DDW: You spent nearly nine years at 10x Genomics taking genomic technologies from concept to launch, and you have just joined Lightcast as […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!